Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice

Detalles Bibliográficos
Autores principales: Delforge, Michel, Vekemans, Marie-Christiane, Depaus, Julien, Meuleman, Nathalie, Van de Velde, Ann, Vande Broek, Isabelle, Vandervennet, Sophie, Van Hoorenbeeck, Sandra, Moorkens, Evelien, Strens, Danielle, Diels, Joris, Ghilotti, Francesca, Haefliger, Benjamin, Dalhuisen, Sander, Deraedt, William, Anguille, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722575/
https://www.ncbi.nlm.nih.gov/pubmed/36479545
http://dx.doi.org/10.1097/HS9.0000000000000813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722575/
https://www.ncbi.nlm.nih.gov/pubmed/36479545
http://dx.doi.org/10.1097/HS9.0000000000000813

Ejemplares similares